We recently found AGK negatively regulates the sensitivity of diffuse large B cell lymphoma (DLBCL) to Venetoclax by phosphorylating PTEN, thus activating PI3K/AKT and in turn inhibiting FOXO1 and enhancing BCL-2 19. Here, BCL2 is linked to diffuse large B-cell lymphoma.